Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Apr;20(2):97–108. doi: 10.7508/ibj.2016.02.005

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 3 — EIT-specific IgG and IgA. Test 1, intranasal immunization with electrosprayed nanoparticles chitosan-rEIT; Test 2, intranasal immunization with electrospraed TMC-rEIT nanoparticles; Control 1, intraperitoneally immunization with rEIT adjuvanted by Freund's adjuvant; Control 2, non-immunized mice nasally administered with chitosan alone; Control 3, non-immunized mice nasally administered with non-electrosprayed chitosan-rEIT. Mice immunization was conducted three times during 42 days. The sera, fecal, and eye wash samples were collected after each immunization and assayed for rEIT-specific responses, including (A) serum IgG titers, (B) serum IgA titers, (C) fecal IgA titers, (D) eye washes IgA titers using an ELISA method. Non-immunized mice and intraperitoneally immunized samples were used as negative and positive control, respectively (P<0.05).